34 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
12 Mar 24
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan
4:01pm
. With Dr. Nathan’s guidance, Gossamer is poised to expand its clinical program for seralutinib to include PH-ILD, underscoring Gossamer’s commitment
8-K
EX-3.1
GOSS
Gossamer Bio Inc
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
, will not become a party to (1) any agreement, arrangement or understanding with, and has not given and will not give any commitment or assurance … Commitment”) or (2) any Voting Commitment that could limit or interfere with such proposed nominee’s ability to comply, if elected as a director
8-K
EX-10.1
ryyw19t
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
PRE 14A
sw8zrn34te8knpn
17 Apr 23
Preliminary proxy
4:01pm
8-K
EX-10.1
5g3sz tejyr8e5xv
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
8-K
EX-10.1
9pc8byf8m
2 Jul 20
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
qbo9z3 ko11l7
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
10-K
mi6nyk7e1ro7cq jo3
22 Mar 19
Annual report
4:45pm